Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome  by Miyazaki, Toshihisa et al.
JACC Vol. 27, No. 5 1061 
April 1996:1061-70 
CLINICAL STUDIES ELECTROPHYSIOLOGY 
Autonomic and Antiarrhythmic Drug Modulation of ST Segment 
Elevation in Patients With Brugada Syndrome 
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ObJectives. We examined the modulatory effects of autonomic 
nervous ystem and antiarrhythmic drugs on the ST segment in 
patients with Brugada syndrome to gain an insight into the 
mechanism of ST segment elevation. 
Background. Right bundle branch block, ST segment elevation 
and ventricular taehyarrhythmias define a distinct clinical and 
electrocardiographic (ECG) syndrome (Brugada syndrome). 
However, the mechanism of ST segment elevation and the causes 
of this syndrome are unknown. 
Methods. The study included four patients in whom structural 
heart or coronary artery disease was excluded by noninvasive and 
invasive tests. High take-off ST segment elevation of either the 
coved or saddle-back type in precordial leads V1, V a and V 3 was 
seen in all patients. Three patients experienced recurrent episodes 
of syncope or aborted sudden cardiac death, and the remaining 
patient had palpitation. Autonomic receptor stimulation and 
blockade and intravenous administration ofantiarrhythmic drugs 
were performed uring sinus rhythm while the 12-lead ECG was 
recorded. Metaiodobenzylguanidine (MIBG) scanning and Holter 
monitoring were also performed. 
Results. Beta-adrenoceptor stimulation by intravenous i opro- 
terenol consistently reduced (>0.1 mV) ST segment elevation at 
or 80 ms after the J point in all four patients. Selective alpha° 
adrenoceptor stimulation by intravenous norepinephrine in the 
presence of propranolol or by intravenous methoxamine consis- 
tently augmented, whereas alpha-adrenoceptor blockade reduced, 
ST segment elevation in three patients. Intracoronary acetylcho- 
line or intravenous edrophonium or neostigmine augmented ST 
segment elevation without inducing coronary spasm in three of 
four patients. Class IA antiarrhythmic drugs also consistently 
augmented (three patients), whereas class IB drugs had no effect 
on (two patients) ST segment elevation. No abnormality was found 
on MIBG imaging or heart rate variability in three patients, 
suggesting that autonomic dysfunction is not a primary disease 
process. Class IA drugs had no effect on ST segment in three 
control patients, suggesting that the ST segment elevation seen in 
patients with Brugada syndrome in response to the drugs is not a 
nonspecific response. 
Conclusions. ST segment elevation in patients with Brugada 
syndrome was augmented by selective stimulation of alpha- 
adrenoceptors or muscarinic receptors or by class IA drugs but 
was mitigated by beta-adrenoceptor stimulation or alpha- 
adrenoceptor blockade. These responses might be explained by 
postulating the presence of an area of early repolarization or a 
local "depolarized" area in the ventricle causing ST segment 
elevation in this syndrome. Because only a small number of 
patients were studied, these possibilities need further evaluation. 
(JAm Coil Cardio11996;27:1061-70) 
In 1992, Brugada and Brugada (1) reported ata on eight 
patients with right bundle branch block, persistent ST segment 
elevation with a normal QT interval and sudden cardiac death 
and proposed that these abnormalities constituted a distinct 
clinical and electrocardiographic (ECG) syndrome, different 
from "idiopathic" ventricular fibrillation without such ECG 
abnormalities (2,3). Structural heart disease or coronary artery 
disease was excluded in most patients by noninvasive and 
invasive tests, but the causes of this syndrome are still un- 
known. 
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In the present report, we refer to such unique ECG findings 
associated with symptoms most likely due to ventricular tachy- 
arrhythmias as Bmgada syndrome. High take-off ST segment 
elevation of either the coved or saddle-back type (4) in 
precordial leads V1 to VJV 3 seems to be a prominent feature 
of this syndrome; however, the mechanism remains to be 
determined. Such ST segment elevation could not be explained 
by electrolyte disturbances, i chemia or structural heart dis- 
ease. Right bundle branch block may lead to an abnormal 
ventricular repolarization; however, the ST segment abnor- 
malities are clearly different from those observed in uncompli- 
cated right bundle branch block (1). A role played by the 
autonomic nervous ystem in this syndrome has been suggested 
(1,5,6). 
In an attempt o gain insight into the mechanism of ST 
segment elevation, we examined the modulatory effects of 
autonomic nervous ystem and antiarrhythmic drugs on ST 
segment in four patients with Brugada syndrome. 
©1996 by the American College of Cardiology 0735-1097/96/$15.00 
Published by Elsevier Science Inc. SSDI 0735-1097(95)00613-3 
1062 MIYAZAKI  ET  AL .  JACC Vo l .  27 ,  No .  5 
ST  SEGMENT ELEVAT ION IN  BRUGADA SYNDROME Apr i l  1996:1061-70  
Table 1. Clinical and Electrocardiographic Characteristics ofFour Male Study Patients 
Pt No./ Arrhythmias ST QTc Interval CAG LVG 
Age (yr)  Syncope Documented Induced Segment Elevation (ms) (Ach test) (EF) RVG Biopsy 
1/29 + SVT VF/SVT v2-g  4 410 Normal Normal NP NP 
(negative) (62%) 
2/47 - PVCs VF Va-V 4 390 Normal Normal NP NP 
(negative) (60%) 
3/41 + - VF Va-V 4 430 Normal Normal NA NA 
(negative*) (74%) 
4/38 + VF - V1-V z 404 Normal Normal NP NP 
(negative) (59%) 
Ach test = acetylcholine provocation test for induction of coronary spasm (*ergonovine was used instead of acetylcholine); biopsy = histologic examination f 
endomyocardial biopsy specimens taken from interventricutar septum; CAG = coronary angiogram; EF = ejection fraction; LVG = left ventriculogram; NA = not 
available; NP = no particular findings; Pt = patient; PVCs = premature v ntricular complexes; QTc interval = corrected QT interval; RVG = right ventriculogram; 
SVT = sustained monomorphic ventricular tachycardia; VF = ventricular fibrillation. 
Methods 
Patients. The study included four male patients, 29 to 47 
years old, with Brugada syndrome under observation for 21 
months. Each patient was treated according to the ethical 
guidelines of our institutions, and written informed consent 
was obtained before the following tests. Table 1 summarizes 
the clinical and ECG characteristics of the patients. During 
sinus rhythm, high take-off ST segment elevation of either the 
coved or saddle-back type was recognized in precordial leads 
V 1 to V~/V 3 in all patients (Fig. 1 to 4). During the hospital 
period, day to day variability in degree of precordial ST 
segment elevation was seen in all patients, especially in Pa- 
tients 3 and 4. Right bundle branch block was diagnosed 
definitively in Patient 1. The QT and corrected QT intervals 
were within normal imits in all patients. Patients 1 and 3 had 
recurrent episodes of syncope after palpitation, and Patient 4 
experienced multiple episodes of aborted sudden cardiac death 
from ventricular fibrillation. ST segment elevation was aug- 
mented in Patient 4 immediately before and shortly after 
spontaneous episodes of ventricular fibrillation that occurred 
during the hospital period. Ventricular fibrillation was termi- 
nated by application of direct current shock (200 J) or spon- 
taneously. Sustained monomorphic ventricular tachycardia of 
left bundle branch configuration (240 beats/rain) causing hy- 
potension was documented in Patient 1. Patient 2 had a history 
of hypertension and complained of palpitation. During Holter 
monitoring, frequent premature ventricular complexes (4,582 
beats/day) were recorded. Although Patient 2 had neither 
syncope nor documented ventricular tachycardia or fibrillation, 
we included him in the present series because of ECG findings 
characteristic of Brugada syndrome and a bout of palpitation 
that appeared attributable to ventricular tachyarrhythmias. 
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Figure 1. Electrocardiograms from Patient 1 
during sinus rhythm. Right bundle branch 
block, left anterior hemiblock, first-degree 
atrioventricular block and high take-off ST seg- 
ment elevation of the coved (leads VI, V2) and 
saddle-back types (lead V3) can be seen. 
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Figure 2. Electrocardiograms from Patient 2 
during sinus rhythm. ST segment elevation of 
the coved (lead V1) and saddle-back types (lead 
V2) can be seen. 
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During electrophysiologic testing, ventricular fibrillation was 
induced in Patients 1, 2 and 3 with single (Patient 1) or double 
extrastimuli (Patients 2 and 3) applied to the right ventricular 
outflow tract. Ventricular fibrillation was induced during base- 
line conditions in Patients 1 and 3 and during alpha- 
adrenoceptor and muscarinic stimulation in Patient 2 (see 
Figure 3. Electrocardiograms from Patient 3 during sinus rhythm. 
Coved-type ST segment elevation can be seen in leads V~ and V2. 
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Autonomic tests). In Patient 1, sustained monomorphic ven- 
trieular tachycardia of the same configuration as the clinical 
one was also induced by single extrastimulus applied to the 
right ventricular apex during beta-adrenoceptor stimulation, 
and neither ventricular fibrillation nor sustained ventricular 
tachycardia was inducible after beta-adrenoceptor blockade with 
intravenous propranolol (see autonomic tests). In Patient 4, 
Figure 4. Electrocardiograms from Patient 4 during sinus rhythm. 
Coved-type ST segment elevation can be seen in leads V1 and V 2. 
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ventricular fibrillation was noninducible, with up to three 
extrastimuli applied to the right ventricular apex and outflow 
tract at baseline and during isoproterenol infusion. 
The AH and HV intervals on the His bundle electrogram 
were normal, except in Patient 1 (HV interval 100 ms). Sinus 
node recovery time and sinoatrial conduction time were nor- 
mal in all patients. Delayed potential during sinus rhythm was 
not recorded from the right ventricle in any patient during 
electrophysiologic testing. Late potential on the signal- 
averaged ECG was positive in Patient 1 (RMS40 8.71 ~V, LAS 
51.0 ms) and negative in Patients 2 and 4. 
All patients had normal findings on physical and neurologic 
examination. Serum electrolyte l vels and renal, hepatic and 
thyroid test results were within normal limits in all patients. 
Chest roentgenographic and echocardiographic findings were 
normal in all patients, and all patients underwent cardiac 
catheterization. Pressure study, cardiac output and right and 
left ventriculographic results were normal in all patients. 
Coronary angiography revealed no stenotic lesions in any 
patient. No inducible coronary spasm was demonstrated by 
intracoronary injection of acetylcholine (up to 50/xg in the 
right coronary artery, up to 100 txg in the left coronary artery) 
in Patients 1, 2 and 4 and by ergonovine in Patient 3. 
Endomyocardial biopsy specimens taken from the interventric- 
ular septum revealed no abnormalities on histologic examina- 
tions in Patients 1, 2 and 4. Thus, structural heart disease or 
coronary artery disease was excluded in all four patients. 
Autonomic tests, Autonomic tests were performed uring 
electrophysiologic testing (Patients 1 and 2) or at bedside (Pa- 
tients 3 and 4) to determine the effects of autonomic receptor 
stimulation and blockade on the ST segment. Twelve-lead ECGs 
were recorded. During sinus rhythm, isoproterenol was infused 
intravenously at a dose of 1 to 2 txg/min for beta-adrenoceptor 
stimulation of the ventricles. Propranolol was injected intrave- 
nously at a dose of 8 mg (0.14 mg/kg as body weight-corrected 
mean dose) for beta-adrenoceptor bl ckade. Intravenous norepi- 
nephrine at a dose of 5 to 12.5 ~g/min after beta-adrenoceptor 
blockade or intravenous methoxamine (6 mg) was used for 
selective stimulation of alpha-adrenoceptors. Intravenous phen- 
tolamine (5 or 10 mg) or oral prazosin (4 mg) was used for 
alpha-adrenoceptor blockade. For muscarinic stimulation, edro- 
phonium (10 rag) or neostigmine (0.5 rag) was injected intrave- 
nously. The acetylcholine provocation test during cardiac cathe- 
terization was also used for muscarinic stimulation of the 
ventricles. 
Administration of antiarrhythmic drugs. Antiarrhythmic 
drugs were injected intravenously to examine their effects on 
the ST segment. Disopyramide (50 rag) or procainamide 
(450 rag) was used as a class IA antiarrhythmic drug, and 
mexiletine (125 rag) or lidocaine (100 rag) was used as a class 
IB drug. Verapamil (5 or 10 rag) was used as a calcium channel 
blocking agent. 
Twelve-lead ECGs were recorded every 1 rain after the 
injection of the drugs or neurotransmitters. Maximal ST 
segment changes (see Results) were observed usually between 
1 and 5 min. When prazosin was administered orally, ECGs 
were recorded every 1 h. 
Autonomic function. Metaiodobenzylquanidine (MIBG) 
scanning was performed to assess the sympathetic innervation 
of the ventricles. To examine the integrated function of the 
autonomic nervous ystem, heart rate variability was analyzed 
by Holter monitoring. 
Control group. The effects of intravenous disopyramide 
(50 mg) or procainamide (200 mg) on the ST segment were 
examined in two patients with classic right bundle branch block 
and without underlying cardiac disease and in one patient with 
hypertrophic cardiomyopathy and ST segment elevation. 
Resu l ts  
Effects of autonomic tests on ST segment. Beta-adreno- 
ceptor stimulation by intravenous isoproterenol consistently 
reduced ST segment elevation by ->0.1 mV at or 80 ms after 
the J point in all four patients (Fig. 5 and 6 [see also Fig. 9, 
later]). In contrast, selective alpha-adrenoceptor stimulation 
increased ST segment elevation in all three patients tudied 
(Patients 1, 2 and 3) (Fig. 5 and 6), whereas alpha- 
adrenoceptor blockade reduced ST segment elevation in all 
patients examined (Patients 2, 3 and 4) (see Fig. 9, later). 
Intracoronary acetylcholine increased ST segment elevation in 
all three patients examined (Patients 1, 2 and 4) (Fig. 5) 
without inducing coronary spasm. Intravenous edrophonium 
also augmented ST segment elevation in two of three patients 
examined (Patients 1 and 2) (Fig. 5 and 6). Intraventricular 
conduction as assessed by HV interval on the His bundle 
electrogram remained unaffected during the autonomic tests in 
Patients 1 and 2. 
Effects of antiarrhythmic drugs on ST segment. Procain- 
amide or disopyramide augmented ST segment elevation in all 
three patients examined (Patients 1, 3 and 4) (Fig. 7 to 9) and 
increased premature ventricular complexes in Patients 1 and 4 
(0 to 42 premature ventricular complexes/rain; 0 to 2 prema- 
ture ventricular complexes/rain, respectively). In Patient 4, 
intravenous nicorandil (8 rag), a potassium channel opener (7), 
reduced ST segment elevation only modestly (0.05 mV) hut 
mitigated isopyramide-induced ST segment elevation (Fig. 9). 
In contrast, neither mexiletine nor lidocaine had any effect 
on the ST segment. Verapamil had no effect on the ST segment 
in Patients 1 and 4 (Fig. 9), and reduced ST segment elevation 
in Patient 3. The effects of autonomic testing and antiarrhyth- 
mic drugs on the ST segment are summarized in Table 2. 
Disopyramide or procainamide did not affect he ST segment 
in the three control patients (Fig. 10), suggesting that ST 
segment elevation in response to these drugs in patients with 
Brugada syndrome is not a nonspecific response. 
Autonomic function. No abnormality was found on MIBG 
imaging or in heart rate variability in all three patients tudied 
(Patients 1, 2 and 4), suggesting that autonomic dysfunction is
not a primary disease process. 
Clinical course. Patient 1 has received propranolol for 8 
months without recurrence of syncope and is scheduled to 
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Figure 5. Effects of autonomic receptor stimula- 
tion (A) and intracoronary acetylcholine (Ach) 
(B) on ST segment elevation i Patient 1. During 
beta-adrenoceptor s imulation by isoproterenol, 
ST segment elevation seen in leads V~ to V 3 at 
baseline condition was eliminated, whereas it was 
augmented, by selective alpha-adrenoceptor 
stimulation with norepinephrine  the presence 
of propranolol r by muscarinic stimulation with 
intravenous edrophonium. STsegment elevation 
was also augmented byintracoronary acetylcho- 
line without induction of coronary spasm (not 
shown). Furthermore, ST segment elevation re- 
mained unchanged by intracoronary isosorbide 
dinitrate (ISDN), suggesting that it was not due 
to ischemia nduced by coronary spasm. Note that 
premature ventricular complexes developed fre- 
quently when ST segment elevation was aug- 
mented but disappeared during isoproterenol in-
fusion, div = continuous intravenous infusion; 
iv = intravenous injection; LAD = left anterior 
descending coronary artery; RCA = right coro- 
nary artery. 
j~ Norepinephrine 
Isoproterenol 12.5 ~ e,/mln ctiv Edrophonium 
Baseline I ~, e,/min aiv Propranolol 8 mg iv 10 mg iv 
} I / 
l sec  
B Baseline Ach 50 ~u g (LAD) Ach 50 U g (R CA) 
Vl ~ - . . - .~  ~ 
v 2 ~ 1  !' ~-~-'--  
ISDN 5 mg(RCA) 
1 see 
receive an implantable cardioverter-defibrillator. Patient 2 has 
been asymptomatic for 8 months after receiving doxazosin 
mesilate for alpha-adrenoceptor blockade, prescribed for 
treatment of hypertension. Patient 3 is scheduled to receive an 
implantable cardioverter-defibrillator. Patient 4 received an 
implantable cardioverter-defibrillator (Ventak PRXII, CPI) 17 
months ago. Ventricular fibrillation recurred three times 
within 1 month after implantation, two of which were termi- 
nated by shock delivery by the device, and the remaining 
episode terminated spontaneously before delivery of shock. 
Since then he has been taking oral mexiletine and remained 
asymptomatic without syncope or ventricular fibrillation for 16 
months. 
Discuss ion  
Electrocardiographic features of Brugada syndrome. Re- 
ports of patients with ECG and clinical findings compatible 
with Brugada syndrome, published before or after the multi- 
center report by Brugada and Brugada (1), can be found 
(5,6,8-10). The most prominent and common ECG feature 
among these patients eems to be a high take-off ST segment 
elevation of either the coved or saddle-back type (4). Such ST 
segment elevation was documented in all our patients. The day 
to day variability in degree of ST segment elevation seen in our 
patients was observed insome previous reports (5,6). Augmen- 
tation of ST segment elevation before and after a spontaneous 
episode of ventricular fibrillation has also been previously 
documented (5), as in our Patient 4. In the present study, we 
showed that autonomic nervous ystem and class IA antiar- 
rhythmic drugs could modulate ST segment elevation pro- 
foundly. 
In contrast, right bundle branch block was not always 
diagnosed efinitively in previous reports. Bjerregaard et al. 
(6) did not interpret ECG patterns of their patients as right 
bundle branch block; rather, they believed that a wide QRS 
complex represented a prominent J wave, most often seen in 
patients with hypothermia. 
Possible mechanisms of ST segment elevation in Brugada 
syndrome as estimated by autonomic tests and antiarrhythmic 
drugs. There are several possible xplanations for ST segment 
elevation i  Brugada syndrome, including intraventricular con- 
duction disturbance, early ventricular epolarization, local 
ventricular "depolarization" and sympathetic imbalance (11). 
Right bundle branch block or intraventricular conduction 
disturbance could be an explanation for ST segment elevation. 
However, the ST segment abnormalities seen in Brugada 
syndrome are clearly different from those observed in uncom- 
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Figure 6. Effect of heart rate (HR) (A) and autonomic receptor 
stimulation and blockade (B) on ST segment elevation in lead V 2 in 
Patient 2. ST segment elevation remained unchanged by right atrial 
(RA) pacing at 100 and 120 beats/rain at baseline (A). In contrast, ST 
segment elevation was reduced by isoproterenol, unaffected by pro- 
pranolol and augmented by selective alpha-adrenoceptor stimulation 
with norepinephrine in the presence of propranolol, or by muscarinic 
stimulation with edrophonium (B). Other abbreviations a  in Figure 5. 
plicated right bundle branch block (1). Delayed potential of 
the right ventricle was not recorded uring electrophysiologic 
testing in our patients. Late potential was positive in only one 
of three patients examined. Furthermore, intraventricular con- 
duction as assessed by HV interval on the His bundle electro- 
gram remained unaffected in Patients 1 and 2 even when ST 
segment elevation was modulated profoundly by autonomic 
tests. These observations suggest that conduction disturbance 
does not appear to be a pivotal mechanism of ST segment 
elevation. 
Early ventricular repolarization or a combination of early 
and delayed ventricular repolarization could cause ST segment 
elevation in this syndrome, and there might be an argument for 
this hypothesis. If the presence of early repolarization causes 
ST segment elevation, class IA antiarrhythmic drugs are ex- 
pected to mitigate the ST segment elevation by prolonging the 
action potential duration of the early repolarized (diseased) 
site, thereby reducing the difference between the diseased and 
normal sites because the drugs are thought o affect the "dis- 
eased" site selectively (12,13). Conversely, beta-adrenoceptor 
stimulation is expected to augment ST segment elevation by 
increasing the difference. In contrast, class IA antiarrhythmic 
drugs and selective stimulation of alpha-adrenoceptors  musca- 
rinic receptors, the interventions that would reduce potassium 
conductance and slow repolarization of the ventricle (14-19), in 
fact augmented ST segment elevation, whereas beta- 
adrenoceptor stimulation, which would increase the potassium 
conductance (20), reduced it. To reconcile the early repolariza- 
tion hypothesis and these responses, it is necessary to postulate 
that the interventions affected the normal or delayed repolariza- 
tion site selectively. However, the QT intervals were not pro- 
longed long enough by the interventions that augmented the ST 
segment elevation to validate this postulation (Fig. 5 to 9). 
There is an another point of view in support of the early 
repolarization hypothesis. Antzelevitch et al. (21) showed that 
a transient outward current-mediated spike and dome (notch) 
configuration in the action potential is more prominent in 
ventricular epicardium than in endocardium and suggested 
that this difference could be a cause of ST segment changes on 
ECG. Furthermore, they demonstrated that the dome portion 
of the epicardial action potential is lost by acetylcholine (10 -5 
tool/liter) (22) and high concentration of extracellular calcium 
(23), probably by an outward shift in the balance of currents 
active at the end of phase 1 of the action potential, principally 
transient outward and inward calcium currents, whereas the 
endocardial action potential response is minimal. Therefore, 
muscarinic stimulation, which suppresses the inward calcium 
current, and alpha-adrenoceptor stimulation, which increases 
intracellular calcium concentration, thus causing a net increase 
in outward current, would suppress the dome of the epicardial 
action potential and give rise to ST segment elevation or the 
early repolarization syndrome on the ECG. In contrast, beta- 
adrenoceptor stimulation might mitigate ST segment elevation 
by increasing inward calcium currents. Also, sodium channel 
blocking agents could produce a marked abbreviation of the 
action potential in the canine ventricular epicardium but not in 
endocardium, thus causing ST segment elevation (24). The ST 
segment responses to autonomic tests and class IA drugs in the 
present study are consistent with these findings in vitro. 
Finally, the finding that loss of the action potential dome with 
the interventions previously described is usually observed in 
right, but not left, ventricular epicardium (21) is also consistent 
with the appearance of ST segment elevation only in the right 
precordial leads in patients with Brugada syndrome. 
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Figure 7. Effect of procainamide onST segment 
elevation i Patient 1. ST segment elevation i
leads V~ to V 3 seen at baseline was augmented by
intravenous (iv) procainamide in a dose-related 
manner, and premature ventricular complexes 
developed. 
Baseline Procainamide 150 mg iv 250 mg iv 450 nag iv 
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Morace et al. (25) reported that isoproterenol reduced, 
whereas propranolol augmented, RST segment elevation, in 
patients with the early repolarization syndrome, a normal 
variant condition. They postulated that isoproterenol exerted 
its effect on a site with slower epolarization, most probably the 
posterobasal region of the heart. Whatever mechanism of ST 
segment elevation operates, the common response to isopro- 
terenol suggests that Brugada syndrome and the early repolar- 
ization syndrome might share at least in part a common 
mechanism that causes ST segment elevation. This possibility 
needs further evaluation. 
If we postulate that there is a local "depolarized" area in 
the ventricle where potassium conductance is reduced for 
some reason, that the rest membrane potential and action 
potential amplitude are reduced and that the interventions 
have affected such areas preferentially, then the ST segment 
responses observed in the present study might be reasonably 
explained. It is known that alpha-adrenoceptor stimulation by 
Figure 8. Effect of intravenous (iv) disopyramide onST 
segment elevation in Patient 3 who was taking oral 
disopyramide (300 mg/day). In this patient, day to day 
variability indegree of ST segment elevation was observed 
before and after the start of oral disopyramide. ST seg- 
ment elevation in leads V 1 to V3 was augmented by 
intravenous administration f disopyramide, and coved- 
type ST segment elevation characteristic of Brugada syn- 
drome developed. However, reinduction of ventricular 
fibrillation was prevented by oral plus intravenous diso- 
pyramide. 
Control 
VI ~,-----~'r----~'r----~'~-,,-J,-----~'~- 
i : J i ~ i 
Disopyramide 50 mg iv 
i i , 
, ; ~ I l i 
i' i 
V 6 ~ k~~. , 'x . . - ,~ '~. , ' x , - . .~ , - -  . 
i i 
1 sec 
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Control Disopymmide 50 mg iv 
V2 
N ~  8 mg + Disopyramide 50 mg iv 
V2 
Mexiletine 125 mg iv 
V2 
Verapm~ 5 rng iv 
, I i , 
Isolloemmol 2,n g / rain div 
A..A.,A.. A.  
V~ , :  I i  
4mgpo 
v,  £ i I 1 i ) 
Figure 9. Effects of autonomic tests and antiarrhythmic drugs on ST 
segment inPatient 4. Day to day variability indegree of ST segment 
elevation was also recognized in this patient during the hospital period, 
and the tests were performed on separate days when ST segment 
elevation was less marked than that in Figure 4. ST segment elevation 
in lead V2 was augmented by intravenous di opyramide, unaffected by
mexiletine orveraparnil and reduced by intravenous isoproterenol, and 
1 h after oral (po) prazosin. Pretreatment wi h intravenous nicorandil, 
a potassium channel opener, mitigated isopyramide-induced ST 
segment elevation. Other abbreviations as in Figure 5. 
norepinephrine, methoxamine or phenylephrine inhibits tran- 
sient outward calcium current in rabbit myocytes (17). This 
effect may slow action potential repolarization and augment 
the depolarization of the rest membrane potentials in the 
depolarized area by decreasing potassium conductance fur- 
ther, thereby augmenting ST segment elevation. Vagal stimu- 
lation might exert a similar effect because it slows ventricular 
repolarization (18,19). The class IA antiarrhythmic drugs used 
Control 
(A) 
(B) 
Vt 
~!ll!llllltli!!lilllii! ~ ~! - 
j , : :  I . 
: l i  ! i i  ~il!l : : 
I d  I i i  - 
(c) 
-i~ ~- t£,:..:., ....... : j ~ i_2= 
Disopyramide 50 mg iv 
! i :  ~!~ ~:! i ~/ 
:7 i "' ~ :1i: , 
J ;F i" 
~ ! : :  ~i,i il 
Procainamide 200 mg iv 
Disopyramide 50 mg iv 
- I  -~  ........ 
1 sec  
Figure I0. Effects of class IA antiarrhythmic drugs on ST segment in
control group atients. Intravenous (iv) disopyramide or procainamide 
had no effect on the ST segment in two patients with classic right 
bundle branch block and premature v ntricular complexes but without 
underlying cardiac disease (A and B) and in a patient with hypertrophic 
cardiomyopathy and ST segment elevation (C). The electrocardio- 
grams recorded before (left) and 5 min after (right) drug injection are 
shown. 
in the present study might also exert a similar effect by 
inhibiting delayed rectifying outward potassium and transient 
outward currents (14,15). This local depolarization hypothesis 
might also explain the high take-off ST segment elevation 
characteristic of Brugada syndrome. 
Abnormal autonomic nnervation or sympathetic imbalance 
(11) may cause ST segment elevation. Morace et al. (25) 
hypothesized that ST segment elevation in patients with the 
early repolarization syndrome was related to an enhanced 
activity of the right cardiac sympathetic nerves. In Brugada 
Table 2. Effects of Autonomic Tests and Antiarrhythmic Drugs on Precordial ST Segment Elevation 
Ca 2+ 
Pt Beta- Beta- :dpha- Alpha- Muscarinie Class IA Class IB Channel 
No. Stimulation Blockade Stimulation Blockade Stimulation Drug Drug Blocker 
t ~ 1' 1' NA ~ ~ ~ 
2 $ ~ 1' ~ ~ NA NA NA 
3 ~ ~ ~ ~ ~ ~ NA 
4 ~ ~ NA ~ ~ ~ ~ 
$ ( 1' ) = reduced (augmented) ST segment elevation by ->0.1 mV at or 80 ms after the J point; ~ = no effect on 
ST segment (<0.1 mV). Abbreviations as in Table 1. 
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syndrome, a role played by the sympathetic nervous ystem has 
also been suggested because 50% the patients reported by 
Brugada and Brugada (1) were controlled with drugs with 
beta-blocking properties. Abnormal circadian rhythm of the 
parasympathetic nervous activity has been also reported (6). 
However, no abnormality was found on MIBG imaging or in 
heart rate variability in our patients, suggesting that abnormal 
innervation of the heart or autonomic dysfunction is not a 
primary disease process. Rather, the autonomic nervous ys- 
tem seems to act as an important modulator in this syndrome. 
Thus, the plausible mechanism of ST segment elevation in 
Brugada syndrome appears to be that of the early repolariza- 
tion hypothesis or the local depolarization hypothesis, or both. 
However, in the clinical setting it is difficult o validate these 
possibilities directly. Monophasic action potentials can be 
recorded with an electrode catheter during electrophysiologic 
testing. However, it is difficult o record ventricular epicardial 
monophasic action potentials. Also, a local depolarized area 
may not be identified with this method because the absolute 
value of the rest membrane potential cannot be measured. 
Because only a small number of patients were examined in
the present study, it is obvious that more patients need to be 
studied to elucidate the pathophysiologic mechanisms of this 
new syndrome. Nevertheless, it is likely that distinct electro- 
physiologic mechanisms are involved in the unique ECG 
findings in patients with Brugada syndrome. On the basis of 
this notion, we think it appropriate to distinguish Brugada 
syndrome from "idiopathic" ventricular fibrillation without 
ECG abnormalities. Therefore, we refer to the clinical entity 
first proposed by Brugada nd Brugada (1) in a multicenter 
report as Brugada syndrome in the present report. 
ST segment elevation and arrhythmias. Marked ST seg- 
ment elevation might cause arrhythmias based on a variety of 
mechanisms. If a local depolarized area exists, arrhythmias due 
to injury current (26) or abnormal automaticity (27) might 
occur. Also, reentrant arrhythmias might occur because con- 
duction over such area would be slowed. If an area of early 
repolarization exists, it may set the stage for reentry due to 
dispersion of repolarization. 
In fact, there was a correlation between the augmentation 
of ST segment elevation and occurrence of premature ventric- 
ular complexes or ventricular fibrillation during the hospital 
period in our Patients 1 and 4. A similar correlation has been 
previously reported (5). Furthermore, class IA antiarrhythmic 
drugs and selective stimulation of alpha-adrenoceptors or musca- 
rinic receptors augmented ST segment elevation and increased 
premature ventricular complexes in our Patients 1 and 4. These 
observations suggest a proarrhythmic potential of class IA drugs 
and a potential benefit of alpha-adrenoceptor blockade in pa- 
tients with Brugada syndrome. It appears worth examining the 
effect of alpha-adrenoceptor bl ckade on the recurrence of lethal 
ventricular tachyarrhythmias in patients with Brugada syndrome 
who have received an implantable cardioverter-defibrillator. 
However, the relation between augmentation f ST seg- 
ment elevation and arrhythmias needs further evaluation for 
several reasons. In a report by Bjerregaard et al. (6), there was 
no definite correlation between the extent of ST segment 
elevation and occurence of polymorphic ventricular tachycar- 
dia and syncope. In our Patient 3, intravenous disopyramide 
also converted inducible ventricular fibrillation to nonsus- 
tained ventricular tachycardia despite the fact that it aug- 
mented ST segment elevation. Mexiletine, which had no effect 
on ST segment, appeared to be effective in preventing the 
recurrence of ventricular fibrillation in our Patient 4. Finally, 
Belhassen et al. (28) reported that class IA antiarrhythmic 
drugs are highly effective in preventing reinduction of ventric- 
ular tachyarrhythmias in patients with idiopathic ventricular 
fibrillation without ECG abnormalities, although such patients 
may belong to a category different from those with Brugada 
syndrome. 
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